Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
31
Participants
Timeline
Start Date
November 30, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2013
Conditions
Adult Healthy Volunteers
Interventions
BIOLOGICAL
TAB08
monoclonal antibody
Trial Locations (1)
150003
Clinical Emergency Hospital of Yaroslavl, Yaroslavl
All Listed Sponsors
lead
Theramab LLC
INDUSTRY
NCT01885624 - Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers | Biotech Hunter | Biotech Hunter